The NIHR is expanding its Translational Research Collaboration (TRC) portfolio to include Parkinson’s disease.
The NIHR PD-TRC will bring together national expertise and infrastructure. It aims to speed up translation of disease-modifying therapies and precision diagnostics in PD and related disorders.
The collaboration will coordinate centres of excellence across academia and the NHS and drive collaborations with industry and charities in PD to widen access to research and help reduce inequalities across the UK.
The NIHR PD-TRC is led by Professor Oliver Bandmann, from NIHR Sheffield Biomedical Research Centre (BRC). He is supported by Professor Camille Carroll, from NIHR Newcastle BRC, and Professor Alistair Noyce at Queen Mary University of London.
NIHR TRCs are UK-wide groups of experts formed via NIHR Biomedical Research Centres (BRCs). They act as hubs, bringing together research communities. They combine expertise to tackle shared challenges.
Karen Walker, Chief Executive, Multiple System Atrophy Trust, said:
“The MSA Trust is proud to support the NIHR-PD-TRC and looks forward to collaborating with the teams around the country engaged in this unique partnership. We appreciate only too well the anguish felt by our MSA community when a preclinical discovery that has held lots of promise, fails to reach the clinical trial stage and we hope to contribute positively to the efforts to move the early phase research forward.”
Find out more about the NIHR Translational Research Collaboration
